Loading provider…
Loading provider…
Hematology & Oncology Physician in Jacksonville, FL
NPI: 1306171871Primary Practice Location
MAYO CLINIC
4500 San Pablo Rd S, Jacksonville, FL
Primary Employer
Mayo Clinic Jacksonville
mayoclinic.org
HQ Phone
Get MD Taimur's Phone Numberphone_androidMobile
Get MD Taimur's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2011 - 2026
GA State Medical License
2014 - 2026
NY State Medical License
2010 - 2011

American Board of Internal Medicine
Hematology
University at Buffalo
Fellowship • Hematology and Medical Oncology
2009 - 2010
Fellowship • Hematology and Medical Oncology
2007 - 2009
Mount Sinai Medical Center of Florida
Residency • Internal Medicine
2004 - 2007
King Edward Medical University
Medical School
Until 2002
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 96413Infusion of chemotherapy into a vein up to 1 hour | 199 | 225 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 136 | 192 |
| 3 | 96375Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 127 | 295 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 123 | 156 |
| 5 | J2405Injection, ondansetron hydrochloride, per 1 mg | 95 | 1,048 |
Authors: Nicole Lamanna, Javier Pinilla-Ibarz, Rami Manochakian, Sikander Ailawadhi, Asher Chanan-Khan
Journal: Blood Adv
Single agent lenalidomide in newly diagnosed multiple myeloma: a retrospective analysis.
Authors: Dan Lebovic, Rachid Baz, Kelvin Lee, Mohamad Hussein, Mehul Patel, Asher Chanan-Khan
Journal: Leuk Lymphoma
Authors: R Wright
Journal: Mayo Clin Proc
Lead Sponsor: Mayo Clinic
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, DRUG: Dexamethasone, DRUG: Ibrutinib, DRUG: Bortezomib
Lead Sponsor: Prothena Biosciences Ltd.
Intervention / Treatment: DRUG: Placebo, DRUG: NEOD001
Lead Sponsor: OrphAI Therapeutics
Intervention / Treatment: DRUG: Rituximab, DRUG: Atezolizumab, DRUG: LAM-002A